• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内拓扑异构酶I募集对p53的依赖性。

p53 dependence of topoisomerase I recruitment in vivo.

作者信息

Mao Y, Okada S, Chang L S, Muller M T

机构信息

Department of Molecular Genetics, The Ohio State University, Columbus 43210, USA.

出版信息

Cancer Res. 2000 Aug 15;60(16):4538-43.

PMID:10969804
Abstract

DNA damage is attended by rapid recruitment of endogenous type I topoisomerase (topo I) into covalent cleavage complexes with genomic DNA in vivo. In contrast, endogenous topoisomerase II alpha and beta are not stimulated by DNA damage. We show that topo I and p53 are able to associate at arrested topo I-genomic DNA covalent complexes in vivo, suggesting that p53 directly stimulates topo I activity and damage to the genome of the afflicted cell. Moreover, cells that express wild-type p53 are most proficient at recruiting topo I after DNA damage; however, the p53 dependence is conditional because topo I recruitment after DNA damage can be restored if p53 mutant cells (containing a single mutant allele) are artificially held in G1. In contrast, p53 null mutants do not recruit topo I after DNA damage under any conditions (although camptothecin-dependent topo I/DNA complexes readily form in the nulls). These results show that topo I activation after DNA damage depends on the p53 status of the cell. It also depends upon the cell cycle in a way that is very different from that observed with DNA replication-dependent, camptothecin-mediated DNA breaks. The data suggest a model where p53 activates topo I, which inflicts additional genomic damage after the initial UV damage events. Topoisomerases therefore contribute to the p53 commitment to apoptosis, and topo I might assist in elimination of DNA-damaged cells as part of the cellular proofreading function inherent in the p53 pathway.

摘要

在体内,DNA损伤伴随着内源性I型拓扑异构酶(拓扑异构酶I)迅速募集到与基因组DNA形成的共价裂解复合物中。相比之下,内源性拓扑异构酶IIα和β不会因DNA损伤而被激活。我们发现,拓扑异构酶I和p53能够在体内停滞的拓扑异构酶I - 基因组DNA共价复合物处结合,这表明p53直接刺激拓扑异构酶I的活性,并对受影响细胞的基因组造成损伤。此外,表达野生型p53的细胞在DNA损伤后最擅长募集拓扑异构酶I;然而,对p53的依赖性是有条件的,因为如果将p53突变细胞(含有单个突变等位基因)人工维持在G1期,DNA损伤后拓扑异构酶I的募集可以恢复。相比之下,p53基因敲除突变体在任何条件下DNA损伤后都不会募集拓扑异构酶I(尽管喜树碱依赖性拓扑异构酶I / DNA复合物在基因敲除细胞中很容易形成)。这些结果表明,DNA损伤后拓扑异构酶I的激活取决于细胞的p53状态。它还以一种与DNA复制依赖性、喜树碱介导的DNA断裂所观察到的方式非常不同的方式依赖于细胞周期。数据表明了一种模型,即p53激活拓扑异构酶I,在最初的紫外线损伤事件后,拓扑异构酶I会造成额外的基因组损伤。因此,拓扑异构酶有助于p53介导的细胞凋亡,并且拓扑异构酶I可能作为p53途径中固有的细胞校对功能的一部分,协助清除DNA受损细胞。

相似文献

1
p53 dependence of topoisomerase I recruitment in vivo.体内拓扑异构酶I募集对p53的依赖性。
Cancer Res. 2000 Aug 15;60(16):4538-43.
2
Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.拓扑异构酶IIα介导E2F-1诱导的化学敏感性,并且是p53介导的转录抑制的靶点。
Cell Biochem Biophys. 2000;33(2):199-207. doi: 10.1385/CBB:33:2:199.
3
Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.
Exp Cell Res. 2000 Feb 25;255(1):86-94. doi: 10.1006/excr.1999.4772.
4
Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.胃癌中DNA拓扑异构酶I、DNA拓扑异构酶II-α和p53的免疫组织化学染色
Anticancer Res. 2001 Mar-Apr;21(2A):1167-72.
5
Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.转化生长因子-β1对拓扑异构酶IIα表达的抑制作用被乳头瘤病毒E7蛋白消除。
Cancer Res. 2000 Dec 15;60(24):6989-94.
6
Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.未治疗及铂/环磷酰胺治疗的恶性卵巢肿瘤中拓扑异构酶I和IIα及β的定量和定性分析
Cancer Res. 1994 Feb 1;54(3):749-55.
7
Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.小鼠红白血病细胞向红细胞分化的定向分化受拓扑异构酶IIα磷酸化改变的调控。
Cancer Res. 1996 Sep 15;56(18):4192-9.
8
Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.葡萄糖调节应激通过在癌细胞G1期细胞周期停滞期间诱导核蛋白酶体导致DNA拓扑异构酶IIα降解。
J Cell Physiol. 1999 Jul;180(1):97-104. doi: 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y.
9
How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?药物诱导的拓扑异构酶I-DNA损伤如何向调节细胞周期检查点、DNA复制和DNA修复的分子相互作用网络发出信号?
Cell Biochem Biophys. 2000;33(2):175-80. doi: 10.1385/CBB:33:2:175.
10
Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.在非小细胞肺癌患者中,拓扑异构酶IIα基因的表达受p53肿瘤抑制基因调控。
Cancer. 2002 Apr 15;94(8):2239-47. doi: 10.1002/cncr.10450.

引用本文的文献

1
RNA interacts with topoisomerase I to adjust DNA topology.RNA 与拓扑异构酶 I 相互作用以调节 DNA 拓扑结构。
Mol Cell. 2024 Sep 5;84(17):3192-3208.e11. doi: 10.1016/j.molcel.2024.07.032. Epub 2024 Aug 21.
2
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.聚(ADP - 核糖)聚合物调节活细胞中DNA拓扑异构酶I(Top1)的核动力学和喜树碱敏感性。
Nucleic Acids Res. 2016 Sep 30;44(17):8363-75. doi: 10.1093/nar/gkw665. Epub 2016 Jul 27.
3
Gold(III) macrocycles: nucleotide-specific unconventional catalytic inhibitors of human topoisomerase I.
金(III)大环化合物:人拓扑异构酶I的核苷酸特异性非常规催化抑制剂。
J Am Chem Soc. 2014 Apr 16;136(15):5670-82. doi: 10.1021/ja412350f. Epub 2014 Apr 2.
4
Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I.前列腺癌抑制蛋白 NKX3.1 与拓扑异构酶 I 的结构和功能相互作用。
Biochem J. 2013 Jul 1;453(1):125-36. doi: 10.1042/BJ20130012.
5
Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.Par-4与拓扑异构酶1结合并减弱其DNA松弛活性。
Cancer Res. 2008 Aug 1;68(15):6190-8. doi: 10.1158/0008-5472.CAN-08-0831.
6
Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53.聚(ADP - 核糖)聚合酶 -1(Parp - 1)拮抗P53介导的拓扑异构酶I依赖性重组刺激作用。
Nucleic Acids Res. 2006 Feb 9;34(3):1036-49. doi: 10.1093/nar/gkj509. Print 2006.
7
Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.人拓扑异构酶I的190 - 210位氨基酸残基是体内酶活性所必需的,但体外并非如此。
Nucleic Acids Res. 2003 Dec 15;31(24):7255-63. doi: 10.1093/nar/gkg927.
8
p53 stimulates human topoisomerase I activity by modulating its DNA binding.p53 通过调节其与 DNA 的结合来刺激人类拓扑异构酶 I 的活性。
Nucleic Acids Res. 2003 Nov 15;31(22):6585-92. doi: 10.1093/nar/gkg846.
9
Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo.DNA甲基转移酶的内源性检测:体内哺乳动物细胞中DNMT1、DNMT2和DNMT3差异活性的证据。
Mol Cell Biol. 2003 Apr;23(8):2709-19. doi: 10.1128/MCB.23.8.2709-2719.2003.
10
Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.人拓扑异构酶I切割复合物在体外通过p53刺激的类重组反应进行修复。
Nucleic Acids Res. 2002 Dec 1;30(23):5087-93. doi: 10.1093/nar/gkf659.